AstraZeneca Calls for UK Govt Commitment to R&D Investment

The transcript discusses the UK's focus on innovation, particularly in life sciences, as highlighted in a recent speech by Richie Sunak. It emphasizes the importance of R&D investment and a stable regulatory environment post-Brexit. The commitment to UK investment is strong, with significant funding in R&D. The NHS faces challenges, but partnerships with the industry aim to improve care models and access to innovation. The potential for regulatory improvements post-Brexit is also explored.

What role does the partnership between the MHRA and NHS England play in innovation?

Evaluate responses using AI:

OFF

What challenges does the NHS face in terms of financial support?

Evaluate responses using AI:

OFF

What changes are needed to get new drugs to patients faster?

Evaluate responses using AI:

OFF